AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | +11.1% | 188 | 0.0% | 0.00% | – |
| Q2 2023 | $9 | +28.6% | 188 | 0.0% | 0.00% | – |
| Q1 2023 | $7 | -30.0% | 188 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.8% | 188 | +58.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 119 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 119 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 119 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 119 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 119 | +83.1% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 65 | -59.6% | 0.00% | – |
| Q3 2020 | $5,000 | +66.7% | 161 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 161 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 161 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |